Auckland bio-fuels pioneer Lanzatech has been named the second "hottest" bio-technology company in the world and 4th hottest for bio-chemicals.

Human trials of a locally developed Parkinson's disease treatment have begun in New Zealand after the first round yielded promising results.

Mandatory emissions standards for new vehicles and an electrical "smart grid" are among a raft of ways New Zealand could tap into a global green economy.

Genome sequencing is “revolutionising” medicine, but could also impact on how society deals with criminals with a genetic predisposition towards violence.

Technology developed by New Zealand's LanzaTech will lie at the heart of a new Taiwanese joint venture.

Why is this internet billionaire so keen on New Zealand? And why are we handing him taxpayers' money to invest? Chris Barton reports.

Securing even a small slice of China's cleantech future will be a boon for Kiwi companies writes Ellen Read

Minister 'unaware' of questions on genetic engineering gains.

Research and development business specialises in NZ's key crop - grass.

Canterbury Scientific Limited opened the doors to its new $1.2 million laboratory complex in Addington a few days before February's devastating earthquake.

Events aim to encourage university researchers and companies to start talking to each other.